Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P. Fortune

The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland

Value in Health

Occupational Health

English

Related publications

Dabigatran Compared With Rivaroxaban vs Warfarin

JAMA Internal Medicine

Internal Medicine

English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes

Cardiovascular Medicine

English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health

Occupational Health

English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health

Occupational Health

English

Rivaroxaban and Apixaban in Orthopaedics

Blood Coagulation and Fibrinolysis

English

PCV142 a Review of the Primary Care Prescribing of Dabigatran Etexilate and Rivaroxaban in Ireland

Value in Health

Occupational Health

English

Cost-Effectiveness of Apixaban Compared to Other Anticoagulants in Patients With Atrial Fibrillation in the Real-World and Trial Settings

Multidisciplinary

English

Cost-Effectiveness of Dabigatran (150 Mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation

American Journal of Cardiology

Cardiovascular Medicine

English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Cardiovascular Medicine

Specialized Nursing

English